Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates
Go back to Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates| (NASDAQ: PASG) | Delayed: 5.66 -0.06 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.72 | 52 Week High | $ | |||
| Open | $5.68 | 52 Week Low | $ | |||
| Day High | $5.85 | P/E | N/A | |||
| Day Low | $5.54 | EPS | $ | |||
| Volume | 34,766 | |||||
